New Delhi: Seven-member committee to examine online drug sale issue

Published On 2015-12-09 07:30 GMT   |   Update On 2015-12-09 07:30 GMT
Advertisement
New Delhi: A seven-member committee has been formed to look into the the issue of online drug sale, Lok Sabha was informed today.

Drugs Consultative Committee (DCC) has constituted a seven-member sub committee to examine the issue of online sale of drugs, while taking care of the risks and concerns related to such sales, Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to Lok Sabha.

"All measures considered necessary for safeguarding the interests of consumers are being taken by the government", he added.

A number of representations have been received from chemists and druggist associations against the online sale of prescription drugs, the minister said.

Similarly a number of representations have also been received to permit such sales, he added.

Replying to another question, Ahir said Ministry of Health and Family Welfare has constituted an expert core committee to review and recommend the revision of National List of Essential Medicines (NLEM) 2011 in the context of contemporary knowledge of use of therapeutic products.

As per the Drugs (Price Control) Order, 2013, 680 medicines are currently under the NLEM.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News